治疗耐火性高级心力衰竭的左心室辅助装置:西澳大利亚的经验
Benjamin Silbert1, Amit Shah2, Lawrence Dembo2
1Intensive Care Unit, Fiona Stanley Hospital, Perth, Western Australia, Australia.
Internal medicine journal
|August 24, 2023
概括
左心室辅助器件 (LVADs) 改善了末期心力衰竭的生存率. 西澳大利亚的LVAD计划显示出优秀的患者结果,超过了生存和生活质量的国际基准.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 心脏衰竭管理的管理
背景情况:
- 左心室辅助器件 (LVAD) 对于管理末期心力衰竭至关重要,可以改善存活率和生活质量.
- 西澳大利亚的LVAD项目使用了新一代设备,包括HeartWare HVAD,HeartMate II和HeartMate 3.
研究的目的:
- 审查西澳大利亚左心室辅助装置 (LVAD) 计划的结果.
- 评估LVAD植入在终期心力衰竭患者中的有效性和安全性.
主要方法:
- 对患者数据和病历进行回顾性分析.
- 专注于新一代LVAD设备,在23年内植入.
主要成果:
- 96%的存活率到医院出院,98%的出院后的日子作为门诊患者度过.
- 1,2,5年的长期存活率 (94%,88%,62%) 超过了国际注册结果.
- 关键并发症包括感染 (36%),胃肠道出血 (19%) 和中风 (11%).
结论:
- 左心室辅助器件 (LVAD) 可以在经过精心挑选的末期心力衰竭患者中取得出色的结果.
- 西澳大利亚计划证明了LVAD的成功实施,特别是在目的地治疗患者中.
相关概念视频
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Heart Failure V: Medical Management
13
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11


